Literature DB >> 10848790

No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence.

M Stanulla1, M Stümm, B O Dieckvoss, K Seidemann, V Schemmel, A Müller Brechlin, M Schrappe, K Welte, A Reiter.   

Abstract

Nijmegen breakage syndrome (NBS) is an autosomal recessive DNA repair disorder with a high predisposition for lymphoid malignancies. The majority of NBS patients carry a homozygous founder mutation (657del5) within the NBS1 gene. The observation of a high incidence of cancer in close relatives of NBS patients suggests a potential pathogenetic role of NBS1 mutations in heterozygotes as well. We assessed the frequency of the 657del5 mutation in 109 paediatric patients with non-Hodgkin's lymphoma (NHL). None of the patients analysed carried a NBS1 allele with the 657del5 mutation, suggesting that this mutation does not play a major role in the pathogenesis of NHL of childhood and adolescence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848790     DOI: 10.1046/j.1365-2141.2000.01973.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

Review 1.  Ataxia-telangiectasia and related diseases.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

2.  First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability.

Authors:  Hiroyuki Shimada; Kimiko Shimizu; Sachiyo Mimaki; Tokuki Sakiyama; Tetsuya Mori; Noriko Shimasaki; Jun Yokota; Kei Nakachi; Tsutomu Ohta; Misao Ohki
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

3.  The frequency of NBN molecular variants in pediatric astrocytic tumors.

Authors:  Dorota Piekutowska-Abramczuk; Elzbieta Ciara; Ewa Popowska; Wiesława Grajkowska; Bozenna Dembowska-Bagińska; Ewa Kowalewska; Aneta Czajńska; Marta Perek-Polnik; Marcin Roszkowski; Małgorzata Syczewska; Małgorzata Krajewska-Walasek; Danuta Perek; Krystyna H Chrzanowska
Journal:  J Neurooncol       Date:  2009-07-22       Impact factor: 4.130

4.  NBS1 Heterozygosity and Cancer Risk.

Authors:  Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

5.  Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.

Authors:  Johanna M Schuetz; Amy C MaCarthur; Stephen Leach; Agnes S Lai; Richard P Gallagher; Joseph M Connors; Randy D Gascoyne; John J Spinelli; Angela R Brooks-Wilson
Journal:  BMC Med Genet       Date:  2009-11-16       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.